Kilitch Drugs (India) Ltd Performance
Day's Low
Day's High
₹303.2₹319.3552 Week's Low
52 Week's High
₹300₹470
| Returns % | |
| 1 Month Return | -3.72 % |
| 3 Month Return | -5.17 % |
| 1 Year Return | -3.52 % |
| Market Stats | |
| Previous Close | ₹313.55 |
| Open | ₹314.75 |
| Volume | 13.72K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹504.26Cr |
Kilitch Drugs (India) Ltd Key Statistics
| P/E Ratio | 30.5 |
| PEG Ratio | 21.94 |
| Market Cap | ₹504.26 Cr |
| P/B Ratio | 2.81 |
| EPS | 8.44 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 8.39 |
Kilitch Drugs (India) Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹504.26 Cr | 33.46% | 0.56 | ₹13 Cr | ₹154 Cr | |
| NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
| NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr | |
| NA | ₹35.53 Cr | 14.76% | 0.54 | NA | NA | |
| NA | ₹111.21 Cr | 51.29% | 0.55 | NA | NA |
About Kilitch Drugs (India) Ltd
Share Price: ₹306.10 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹504.26Cr as of today
Revenue: ₹47.47Cr as on September 2024 (Q3 24)
Net Profit: ₹8.61Cr as on September 2024 (Q3 24)
Listing date: 29 Sep, 2010
Chairperson Name: Mukund P Mehta
| Organisation | Kilitch Drugs (India) Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Kilitch Drugs (India) Ltd
Kilitch Healthcare India Receives Warning Letter from USFDA - 12 Apr, 2024
The US Food and Drug Administration (USFDA) has issued a warning letter to Kilitch Healthcare India for manufacturing lapses, including packing drugs in insanitary conditions at its Maharashtra-based plant. The Navi-Mumbai plant produces finished pharmaceuticals.
Kilitch Healthcare India Receives Warning Letter from USFDA - 11 Apr, 2024
The US Food and Drug Administration (USFDA) has issued a warning letter to Kilitch Healthcare India for significant violations of current good manufacturing practice regulations, including packing drugs in insanitary conditions at its Maharashtra-based plant.
Insights on Kilitch Drugs (India) Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 36.03 Cr → 52.64 Cr (in ₹), with an average increase of 31.6% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 1.34 Cr → 8.62 Cr (in ₹), with an average increase of 84.5% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 23.6%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 62.1%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 69.23% of holdings in Sep 2024 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 30.77% to 30.76% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, KILITCH stock has moved down by -6.1%
Kilitch Drugs (India) Ltd Financials
Kilitch Drugs (India) Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 69.23% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 30.76% | ||
| Others | 0% | 0.00 |
Kilitch Drugs (India) Ltd Key Indicators
Kilitch Drugs (India) Ltd Valuation
Kilitch Drugs (India) Ltd in the last 5 years
Lowest (-986.00x)
July 3, 2019
Today (30.50x)
November 19, 2024
Industry (54.42x)
November 19, 2024
Highest (363.79x)
October 16, 2020
Kilitch Drugs (India) Ltd Earnings and Dividends
Kilitch Drugs (India) Ltd Earnings Results
Kilitch Drugs (India) Ltd’s net profit jumped 81.86% since last year same period to ₹8.62Cr in the Q2 2024-2025. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated 543.28% jump in its net profits since last 3-months.
Read More about Earnings ResultsKilitch Drugs (India) Ltd Dividends May,2019
In the quarter ending March 2019, Kilitch Drugs (India) Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.16%.
Read More about Dividends
Kilitch Drugs (India) Ltd Technicals Summary
Bearish
Neutral
Bullish
Kilitch Drugs (India) Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Kilitch Drugs (India) Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Kilitch Drugs (India) Ltd shares.
Kilitch Drugs (India) Ltd (KILITCH) share price today is ₹306.1
Kilitch Drugs (India) Ltd is listed on NSE
Kilitch Drugs (India) Ltd is listed on BSE
- Today’s highest price of Kilitch Drugs (India) Ltd is ₹319.35.
- Today’s lowest price of Kilitch Drugs (India) Ltd is ₹303.2.
PE Ratio of Kilitch Drugs (India) Ltd is 30.5
PE ratio = Kilitch Drugs (India) Ltd Market price per share / Kilitch Drugs (India) Ltd Earnings per share
Today’s traded volume of Kilitch Drugs (India) Ltd(KILITCH) is 13.72K.
Today’s market capitalisation of Kilitch Drugs (India) Ltd(KILITCH) is ₹504.26Cr.
| Kilitch Drugs (India) Ltd(KILITCH | Price |
|---|---|
52 Week High | ₹470 |
52 Week Low | ₹300 |
Kilitch Drugs (India) Ltd(KILITCH) share price is ₹306.1. It is down -34.87% from its 52 Week High price of ₹470
Kilitch Drugs (India) Ltd(KILITCH) share price is ₹306.1. It is up 2.03% from its 52 Week Low price of ₹300
| Kilitch Drugs (India) Ltd(KILITCH | Returns |
|---|---|
1 Day Returns | -7.45% |
1 Month Returns | -3.72% |
3 Month Returns | -5.17% |
1 Year Returns | -3.52% |